NCT00729599已完成3 期
Single Site Study, Phase III, for Safety Dermatological Evaluation: Basic Acceptability With Odontological Follow up - Cepacol Teen.
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Sanofi
- 入组人数
- 31
- 试验地点
- 1
- 主要终点
- Patients will be evaluated according to the adverse reactions and the intensity of them.
研究概览
简要总结
To prove the safety, in normal conditions, of the Cepacol Teen, a formulation to odontological usage.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 10 Years 至 60 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Integral buccal mucous (without oral pathologies);
- •Normal odontological exams;
排除标准
- •Lactation or gestational risk or gestation;
- •Use of Antiinflammatory or immunosuppression drugs 15 days before the study;
- •Being in odontological treatment;
- •Pathological or mucous disease which can interfere or active gynaecological disease which may interfere wtih study results;
- •Personal history of allergic disease in the area to be treated;
- •Allergic or atopic history;
研究组 & 干预措施
1
Experimental
Cetylpyridinium chloride during 21 consecutive days.
干预措施: Cetylpyridinium chloride (Drug)
结局指标
主要结局
Patients will be evaluated according to the adverse reactions and the intensity of them.
时间窗: 21 days
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Safety Oral Mucosa Evaluation - Acceptability With Odontological Follow up - Cepacol Canela PowerHealthyNCT00687037Sanofi30
已完成
3 期
Dermacyd PH_DESILSTY_FR (Lactic Acid) - Acceptability - Stay on FrutalHygieneNCT00932945Sanofi32
已完成
3 期
Dermacyd Silver Frutal (Lactic Acid) - Acceptability.HygieneNCT00933413Sanofi30
已完成
3 期
Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Sweet FlowerHygieneNCT00663273Sanofi30
已完成
3 期
Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd BreezeHygieneNCT00664391Sanofi32